MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.
Explore how genetic testing aids early diagnosis and personalized management of Yao syndrome, enhancing patient care with targeted treatments and family planning insights.
Unravel ZTTK syndrome's genetic mysteries with insights on SON mutations, diagnosis challenges, genetic testing advances, and tailored management strategies.
Understand the role of genetic testing in diagnosing and managing acute infantile liver failure syndrome. Gain insights into genetic mutations, early diagnosis, and treatment…
Explore how genetic testing, particularly the identification of the ARHGAP31 gene variant, aids in diagnosing and managing Adams-Oliver Syndrome 6 effectively.
Explore how genetic testing unlocks the potential to diagnose and manage Advanced Sleep Phase Syndrome 3, a disorder affecting circadian rhythms and sleep patterns.
Explore genetic testing for Agammaglobulinemia 8, offering early diagnosis, personalized treatment, and genetic counseling, improving outcomes and research insights.
Genetic testing advances ADMIO2 diagnosis by identifying mutations early, enhancing treatment, and guiding family planning in this rare multisystem infantile-onset disorder.
Genetic testing enhances early diagnosis and personalized treatment of CMT2W, offering insights for family planning, research, and improved patient outcomes.